Logística de medicamentos e materiais em um hospital do interior do Rio Grande do Sul.

Abstract

The hospital pharmacy has as main function to assure the quality of care provided to the patient, promoting the safe and rational use of medicines and related, this being the exclusive responsibility of the pharmacist. Hospital logistics is defined as a set of complex and relevant operations for hospital organizations, the union between logistics and management, both efficient, well implemented and updated, can result in cost reduction without changing the level of quality in the services provided and even improve them. However, for a quality flow to occur in hospital care, it is necessary to have effective control of the stock of supplies, such as medicines and materials. In order to efficiently control the levels of stored items, different tools are used, such as inventory classifications, among them, maximum, minimum and security inventory, helping the purchasing sector to make decisions about purchases or replacements of items in stock. The objective of this study was to evaluate the distribution of items in the ABC curve and the logistics processes in the hospital pharmacy, where the steps of purchasing, receiving, storing and distributing drugs and materials were analyzed, targeting the product classes that generate the greatest financial impact on costs from hospital. The study was carried out in the central hospital pharmacy and in the purchasing and receiving sectors of the Hospital Ana Nery (HAN), which was composed of the first 100 items, among medicines and materials, related in the ABC curve of consumption of the central pharmacy, generated by the system Philips Tasy®, in the 12-month period. The results showed that the ABC curve of the central pharmacy consists of a total of 750 items, of which 40 (5.33%) were classified as A, 74 (9.87%) in B and 636 (84.8%) in the curve C. The cost values corresponding to each curve were R $ 1,121,448.96 (69.51%), R $ 328.140.24 (20.34%) and R $ 163.744.80 (10.15%), respectively. The drug that most affected costs was the monoclonal antibody palivizumab 100mg lyophilized powder with an annual value of R $ 173,949.36 (10.78%), however, injectable antibiotics were the class that accumulated more drug expenses, with a value total of R $ 349,435.92 (24.54%). On the other hand, the material group generated an annual expense of R $ 283,509.36 (19.91%), especially for infusion pump equipment with a cost of R $ 56,528.28 (3.5%). Through this work we were able to evaluate the distribution of the items in the ABC curve, the logistics processes in the hospital pharmacy and analyzed the steps of purchasing, receiving, storing and distributing drugs and materials. Key words: hospital purchases, stock.